GENE ONLINE|News &
Opinion
Blog

Astellas Pharma
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
Weekly in Asia|Dec-3
2020-01-02
M&A
Astellas Procures Xyphos Biosciences as Second Acquisition in December
2019-12-31
Weekly in Asia|Dec
2019-12-11
Weekly in Asia|Nov-2
2019-11-27
Weekly in Asia|Nov
2019-11-07
Weekly in Asia | SEP-2
2019-09-24
Weekly in Asia 20190609-0615
2019-06-21
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
1 2 3
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top